BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34582650)

  • 1. LGR5, HES1 and ATOH1 in Young Rectal Cancer Patients in Egyptian.
    Morsy H; Gaballah A; Samir M; Nakundi V; Shamseya M; Mahrous H; Ghazal A; Hashish M; Arafat W
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2819-2830. PubMed ID: 34582650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Uchida K; Mohri Y; Kusunoki M
    Int J Oncol; 2012 Nov; 41(5):1643-52. PubMed ID: 22923071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Kawamura M; Okugawa Y; Okigami M; Hiro J; Uchida K; Mohri Y; Kusunoki M
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):131-8. PubMed ID: 22986809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screen for modulators of atonal homolog 1 gene expression using notch pathway-relevant gene transcription based cellular assays.
    Zeng X; Kirkpatrick R; Hofmann G; Grillot D; Linhart V; Viviani F; Marino J; Boyer J; Graham TL; Lu Q; Wu Z; Benowitz A; Cousins R
    PLoS One; 2018; 13(12):e0207140. PubMed ID: 30540745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
    Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
    Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acquisition of malignant potential in colon cancer is regulated by the stabilization of Atonal homolog 1 protein.
    Kano Y; Tsuchiya K; Zheng X; Horita N; Fukushima K; Hibiya S; Yamauchi Y; Nishimura T; Hinohara K; Gotoh N; Suzuki S; Okamoto R; Nakamura T; Watanabe M
    Biochem Biophys Res Commun; 2013 Mar; 432(1):175-81. PubMed ID: 23333391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atoh1
    Castillo-Azofeifa D; Fazio EN; Nattiv R; Good HJ; Wald T; Pest MA; de Sauvage FJ; Klein OD; Asfaha S
    EMBO J; 2019 Feb; 38(4):. PubMed ID: 30635334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1 Represses ATOH1 via PDK4 and Energy Metabolism and Regulates Intestinal Stem Cell Fate.
    Gao Y; Yan Y; Tripathi S; Pentinmikko N; Amaral A; Päivinen P; Domènech-Moreno E; Andersson S; Wong IPL; Clevers H; Katajisto P; Mäkelä TP
    Gastroenterology; 2020 Apr; 158(5):1389-1401.e10. PubMed ID: 31930988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.
    Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C
    Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
    Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
    Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study.
    Wang X; Fu Y; Chen X; Ye J; Lü B; Ye F; Lü W; Xie X
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):989-96. PubMed ID: 20091184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
    Hou MF; Chen PM; Chu PY
    BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer.
    Yuan R; Ke J; Sun L; He Z; Zou Y; He X; Chen Y; Wu X; Cai Z; Wang L; Wang J; Fan X; Wu X; Lan P
    Clin Exp Metastasis; 2015 Feb; 32(2):169-79. PubMed ID: 25636905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer.
    Imaizumi K; Suzuki T; Kojima M; Shimomura M; Sakuyama N; Tsukada Y; Sasaki T; Nishizawa Y; Taketomi A; Ito M; Nakatsura T
    Cancer Sci; 2020 Jan; 111(1):23-35. PubMed ID: 31660687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
    Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
    Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
    Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
    Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.